Not yet recruiting
Squamous cell carcinoma of the oral cavity+1
Not yet recruitingRegistered drugNo placebo
Study of neoadjuvant intratumoral ipilimumab combined with systemic nivolumab in patients with locally advanced resectable oral cavity squamous cell carcinoma
Registered drugNo placebo
- Disease:Squamous cell carcinoma of the oral cavityLip and/or oral cavity cancer
- Substances:IpilimumabNivolumab
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Ipilimumab
- Sponsor:Amsterdam UMC Stichting
